Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 25

1.

Selection of an optimal macrocyclic chelator improves the imaging of prostate cancer using cobalt-labeled GRPR antagonist RM26.

Mitran B, Thisgaard H, Rinne S, Dam JH, Azami F, Tolmachev V, Orlova A, Rosenström U.

Sci Rep. 2019 Nov 19;9(1):17086. doi: 10.1038/s41598-019-52914-y.

2.

Bispecific GRPR-Antagonistic Anti-PSMA/GRPR Heterodimer for PET and SPECT Diagnostic Imaging of Prostate Cancer.

Mitran B, Varasteh Z, Abouzayed A, Rinne SS, Puuvuori E, De Rosa M, Larhed M, Tolmachev V, Orlova A, Rosenström U.

Cancers (Basel). 2019 Sep 14;11(9). pii: E1371. doi: 10.3390/cancers11091371.

3.

Evaluation of Tumor-Targeting Properties of an Antagonistic Bombesin Analogue RM26 Conjugated with a Non-Residualizing Radioiodine Label Comparison with a Radiometal-Labelled Counterpart.

Oroujeni M, Abouzayed A, Lundmark F, Mitran B, Orlova A, Tolmachev V, Rosenström U.

Pharmaceutics. 2019 Aug 2;11(8). pii: E380. doi: 10.3390/pharmaceutics11080380.

4.

Synthesis and Preclinical Evaluation of Radio-Iodinated GRPR/PSMA Bispecific Heterodimers for the Theranostics Application in Prostate Cancer.

Abouzayed A, Yim CB, Mitran B, Rinne SS, Tolmachev V, Larhed M, Rosenström U, Orlova A.

Pharmaceutics. 2019 Jul 23;11(7). pii: E358. doi: 10.3390/pharmaceutics11070358.

5.

Trastuzumab cotreatment improves survival of mice with PC-3 prostate cancer xenografts treated with the GRPR antagonist 177 Lu-DOTAGA-PEG2 -RM26.

Mitran B, Rinne SS, Konijnenberg MW, Maina T, Nock BA, Altai M, Vorobyeva A, Larhed M, Tolmachev V, de Jong M, Rosenström U, Orlova A.

Int J Cancer. 2019 Dec 15;145(12):3347-3358. doi: 10.1002/ijc.32401. Epub 2019 May 23.

6.

Increased Expression of GLP-1R in Proliferating Islets of Men1 Mice is Detectable by [68Ga]Ga-DO3A-VS-Cys40-Exendin-4 /PET.

Monazzam A, Lau J, Velikyan I, Li SC, Razmara M, Rosenström U, Eriksson O, Skogseid B.

Sci Rep. 2018 Jan 15;8(1):748. doi: 10.1038/s41598-017-18855-0.

7.

High Contrast PET Imaging of GRPR Expression in Prostate Cancer Using Cobalt-Labeled Bombesin Antagonist RM26.

Mitran B, Thisgaard H, Rosenström U, Dam JH, Larhed M, Tolmachev V, Orlova A.

Contrast Media Mol Imaging. 2017 Aug 10;2017:6873684. doi: 10.1155/2017/6873684. eCollection 2017.

8.

Species differences in pancreatic binding of DO3A-VS-Cys40-Exendin4.

Eriksson O, Rosenström U, Selvaraju RK, Eriksson B, Velikyan I.

Acta Diabetol. 2017 Nov;54(11):1039-1045. doi: 10.1007/s00592-017-1046-2. Epub 2017 Sep 11.

9.

Fully automated GMP production of [68Ga]Ga-DO3A-VS-Cys40-Exendin-4 for clinical use.

Velikyan I, Rosenstrom U, Eriksson O.

Am J Nucl Med Mol Imaging. 2017 Jul 15;7(3):111-125. eCollection 2017.

10.

Aryl Sulfonamide Inhibitors of Insulin-Regulated Aminopeptidase Enhance Spine Density in Primary Hippocampal Neuron Cultures.

Diwakarla S, Nylander E, Grönbladh A, Vanga SR, Khan YS, Gutiérrez-de-Terán H, Sävmarker J, Ng L, Pham V, Lundbäck T, Jenmalm-Jensen A, Svensson R, Artursson P, Zelleroth S, Engen K, Rosenström U, Larhed M, Åqvist J, Chai SY, Hallberg M.

ACS Chem Neurosci. 2016 Oct 19;7(10):1383-1392. Epub 2016 Aug 8.

PMID:
27501164
11.

Feasibility of Multiple Examinations Using (68)Ga-Labelled Collagelin Analogues: Organ Distribution in Rat for Extrapolation to Human Organ and Whole-Body Radiation Dosimetry.

Velikyan I, Rosenström U, Bulenga TN, Eriksson O, Antoni G.

Pharmaceuticals (Basel). 2016 Jun 6;9(2). pii: E31. doi: 10.3390/ph9020031.

12.

Identification of Drug-Like Inhibitors of Insulin-Regulated Aminopeptidase Through Small-Molecule Screening.

Engen K, Rosenström U, Axelsson H, Konda V, Dahllund L, Otrocka M, Sigmundsson K, Nikolaou A, Vauquelin G, Hallberg M, Jenmalm Jensen A, Lundbäck T, Larhed M.

Assay Drug Dev Technol. 2016 Apr;14(3):180-93. doi: 10.1089/adt.2016.708.

PMID:
27078680
13.

Selection of optimal chelator improves the contrast of GRPR imaging using bombesin analogue RM26.

Mitran B, Varasteh Z, Selvaraju RK, Lindeberg G, Sörensen J, Larhed M, Tolmachev V, Rosenström U, Orlova A.

Int J Oncol. 2016 May;48(5):2124-34. doi: 10.3892/ijo.2016.3429. Epub 2016 Mar 9.

PMID:
26983776
14.

Binding to and Inhibition of Insulin-Regulated Aminopeptidase by Macrocyclic Disulfides Enhances Spine Density.

Diwakarla S, Nylander E, Grönbladh A, Vanga SR, Khan YS, Gutiérrez-de-Terán H, Ng L, Pham V, Sävmarker J, Lundbäck T, Jenmalm-Jensen A, Andersson H, Engen K, Rosenström U, Larhed M, Åqvist J, Chai SY, Hallberg M.

Mol Pharmacol. 2016 Apr;89(4):413-24. doi: 10.1124/mol.115.102533. Epub 2016 Jan 14.

PMID:
26769413
15.

Dosimetry of [(177)Lu]-DO3A-VS-Cys(40)-Exendin-4 - impact on the feasibility of insulinoma internal radiotherapy.

Velikyan I, Bulenga TN, Selvaraju R, Lubberink M, Espes D, Rosenström U, Eriksson O.

Am J Nucl Med Mol Imaging. 2015 Jan 15;5(2):109-26. eCollection 2015.

16.

The effect of macrocyclic chelators on the targeting properties of the 68Ga-labeled gastrin releasing peptide receptor antagonist PEG2-RM26.

Varasteh Z, Mitran B, Rosenström U, Velikyan I, Rosestedt M, Lindeberg G, Sörensen J, Larhed M, Tolmachev V, Orlova A.

Nucl Med Biol. 2015 May;42(5):446-454. doi: 10.1016/j.nucmedbio.2014.12.009. Epub 2014 Dec 20.

PMID:
25684649
17.

Inhibition of Insulin-Regulated Aminopeptidase (IRAP) by Arylsulfonamides.

Borhade SR, Rosenström U, Sävmarker J, Lundbäck T, Jenmalm-Jensen A, Sigmundsson K, Axelsson H, Svensson F, Konda V, Sköld C, Larhed M, Hallberg M.

ChemistryOpen. 2014 Dec;3(6):256-63. doi: 10.1002/open.201402027. Epub 2014 Nov 21.

18.

The effect of mini-PEG-based spacer length on binding and pharmacokinetic properties of a 68Ga-labeled NOTA-conjugated antagonistic analog of bombesin.

Varasteh Z, Rosenström U, Velikyan I, Mitran B, Altai M, Honarvar H, Rosestedt M, Lindeberg G, Sörensen J, Larhed M, Tolmachev V, Orlova A.

Molecules. 2014 Jul 17;19(7):10455-72. doi: 10.3390/molecules190710455.

19.

Synthesis and preclinical evaluation of 68Ga-labeled collagelin analogs for imaging and quantification of fibrosis.

Velikyan I, Rosenström U, Estrada S, Ljungvall I, Häggström J, Eriksson O, Antoni G.

Nucl Med Biol. 2014 Oct;41(9):728-36. doi: 10.1016/j.nucmedbio.2014.06.001. Epub 2014 Jun 9.

PMID:
25023066
20.

Novel pseudopeptides incorporating a benzodiazepine-based turn mimetic--targeting Mycobacterium tuberculosis ribonucleotide reductase.

Nurbo J, Ericsson DJ, Rosenström U, Muthas D, Jansson AM, Lindeberg G, Unge T, Karlén A.

Bioorg Med Chem. 2013 Apr 1;21(7):1992-2000. doi: 10.1016/j.bmc.2013.01.020. Epub 2013 Jan 18.

PMID:
23395111

Supplemental Content

Loading ...
Support Center